March
OneVentures pumps up artificial heart group BiVACOR
Sydney-based venture capital investor OneVentures is bankrolling an $18 million funding round for heart device company BiVACOR.
- Anthony Macdonald, Sarah Thompson, Kanika Sood and Emma Rapaport
‘Power to control’: why this chef is hooked on jiu-jitsu
Aside from the kitchens at his three restaurants, Alessandro Pavoni’s other happy place is the gym.
- Updated
- Philippa Coates
ACL shareholder likes Healius takeover thinking, increases stake
Boutique fund manager Ethical Partners has lifted its ownership in ACL to 8.7 per cent from 7.7 per cent.
- Anthony Macdonald, Sarah Thompson, Kanika Sood and Emma Rapaport
JPMorgan desk peels off whopper $421m CSL trade
JPMorgan’s equities desk has peeled off one of the biggest during-market-hours trades of the year, crossing a $421 million stake in the ASX200’s fourth largest member CSL.
- Anthony Macdonald, Sarah Thompson, Kanika Sood and Emma Rapaport
Healius asks takeovers tsar to curb hostile suitor
Healius has asked the Takeovers Panel to order ACL correct its “misleading” and “inadequate” hostile takeover bid, and restrain ACL from contacting Healius shareholders.
- Elouise Fowler
Healius slings ACL bid to Takeovers Panel
The development comes a day after Healius’ largest shareholders, Perpetual and John Wylie’s Tanarra Capital, declined to support ACL’s bid.
- Updated
- Elouise Fowler
Estia shares surge on $775m takeover
The aged care provider told investors that Bain Capital had made an approach to the company earlier in the week.
- Elouise Fowler
Why white-collar workers are paying $799 to be punched in the face
Plenty of 30-somethings and 40-somethings dream of stepping into a ring to weave, slip and hopefully land a direct hit.
- Emma Connors
Amcal owner cuts debt, prepares for bleak economy
Sigma Healthcare has swung back to a narrow profit and slashed its debt to cut exposure to interest rate hikes.
- Elouise Fowler
Gresham gets a bait on Healius, rivals scramble for mandates
Bankers have gone running back to their PE and infrastructure manager mates, promising them that Healius is now in play.
- Anthony Macdonald, Sarah Thompson and Kanika Sood
ACL unlikely to succeed with Healius offer: analysts
The hostile takeover bid for larger rival healthcare company is unlikely to succeed due to price, and dim prospects for approval from the competition regulator.
- Elouise Fowler
Rural medical practices biz Ochre Health shops controlling stake
Rural medical practices business Ochre Health has parked its IPO ambitions as equity capital markets remain testy and asked Highbury Partnership to instead find it a buyer willing to take a controlling stake.
- Anthony Macdonald, Sarah Thompson and Kanika Sood
ACCC looms over ACL’s ‘brave’ play for Healius
Under the proposed deal, Healius shareholders would own 68 per cent of the combined group and 32 per cent would be owned by ACL.
- Elouise Fowler and Carrie LaFrenz
Opportunistic Clinical Labs tries to pull off dream deal with Healius
The window opened for private equity-backed pathology group Australian Clinical Labs - and it jumped.
- Anthony Macdonald, Sarah Thompson and Kanika Sood
Why this fund manager is happy to take an ice bath
Wim Hof, known to millions as the ‘Ice Man’ for his advocacy around how deep breathing and cold showers can transform people, has found a new backer in Geoff Wilson.
- Jemima Whyte
Crescent Capital’s turn to tread down continuation path
The private equity investor is thinking about knocking together a new syndicate of investors to invest in its healthcare staffing business, Healthcare Australia.
- Anthony Macdonald, Sarah Thompson and Kanika Sood
Brookfield taps arrangers, cornerstones for $1.6b Healthscope deal
CBA is on the ticket, along with three offshore lenders. Sydnication is set to begin.
- Updated
- Anthony Macdonald, Sarah Thompson and Kanika Sood
Mercury Capital checks back into health with Avive
Mercury Capital’s ruled off the 10th and final investment in its $600 million Fund 3, in a deal that sees it re-enter Australia’s hospitals sector.
- Anthony Macdonald, Sarah Thompson and Kanika Sood
- Exclusive
- Cancer
Cancer charity denies responsibility for drug-trial failure
There are contradictory explanations over the cancellation of testing of a ‘miracle’ cancer cure.
- Aaron Patrick
Carbon fibre wheels group Partington.cc pedals for fresh funds
The company backed by Cadel Evans and chaired by a former UBS managing director wants capital to invest into its business.
- Anthony Macdonald, Sarah Thompson and Kanika Sood
